JPMorgan Highlights American Express and Liberty Energy in October Stock Picks
JPMorgan Adds American Express and Liberty Energy to October Overweight List
UnitedHealthcare and Humana unveil 2027 Medicare Advantage plans
UnitedHealthcare and Humana unveil 2027 Medicare Advantage plans while reducing benefits, narrowing networks, and offering fewer choices for seniors.
-400x300.webp)
Politics Is Creeping Into Investment Portfolios. The Cost Can Be Higher Than You Think
Politically branded ETFs charge higher fees and trail broader market returns while holding identical stocks to standard index funds.
-400x300.webp)
Retailers Gain Margin Power While Packaged Food Brands Falter
Private-label packaged goods sales hit $330B in the US as retailers expand store brands while branded food makers struggle with falling volumes.
G7 Agrees to Release 100M Barrels of Oil and Diesel
G7 Agrees to Release 100 Million Barrels of Oil and Diesel Over Four Months
Alaska Air Is Going Upmarket. New Suites and Premium Economy Arrive in 2028
Alaska Air Group announced a $600M investment to add new lie-flat suites and premium economy cabins across its fleet by 2028 to boost profit growth.
United Airlines Splits Domestic First Class Into Three Fare Tiers
United Is Adding a Cheaper First Class Fare That Strips Seat Selection and Changes
September Hiring Slumps to 29K as Earlier Job Gains Get Cut
US Payrolls Rise Just 29,000 in September as Revisions Cut 60,000 From Prior Months
Wall Bank Strategists Call Magnificent Seven Pullback Buying Opportunity
Big Tech valuation premium shrinks to 10% as Wall Street banks call the recent sell-off an attractive buying opportunity despite soaring AI capex.
Smart Glasses Are Becoming Big Tech’s Next Battleground. These Stocks Could Benefit
Smart glasses shipments quadrupled in 2025 as AI agents challenge traditional smartphones, driving massive growth for hardware suppliers and manufacturers.
Vylor Debuts on NYSE After Completing Corteva Spinoff
Vylor completes its spinoff from Corteva and begins trading on the NYSE as an independent seed and genetics company with ambitious sales targets.
